Andrew Neil Charles Weir
Directeur Général chez Sitryx Therapeutics Ltd.
Postes actifs de Andrew Neil Charles Weir
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/04/2018 | - |
| Directeur Général | 01/04/2018 | - |
Historique de carrière de Andrew Neil Charles Weir
Statistiques
Internationale
| Royaume-Uni | 2 |
Opérationnelle
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorielle
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
- Bourse
- Insiders
- Andrew Neil Charles Weir
- Expérience
